Congshan Jiang Selected Research

pristane (pristan)

1/2021	Pristane promotes anaerobic glycolysis to facilitate proinflammatory activation of macrophages and development of arthritis.
1/2021	Loss of microRNA-147 function alleviates synovial inflammation through ZNF148 in rheumatoid and experimental arthritis.
11/2020	Up-regulated DERL3 in fibroblast-like synoviocytes exacerbates inflammation of rheumatoid arthritis.
1/2020	Upregulated PKM2 in Macrophages Exacerbates Experimental Arthritis via STAT1 Signaling.
1/2017	Increased expression of Th17 cytokines and interleukin-22 correlates with disease activity in pristane-induced arthritis in rats.
1/2017	Pristane induces autophagy in macrophages, promoting a STAT1-IRF1-TLR3 pathway and arthritis.
2/2015	Pristane primed rat T cells enhance TLR3 expression of fibroblast-like synoviocytes via TNF-α initiated p38 MAPK and NF-κB pathways.
1/2014	MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats.
4/2012	Induction of toll-like receptor 2 positive antigen-presenting cells in spleen of pristane-induced arthritis in rats.
6/2011	Arthritis is associated with T-cell-induced upregulation of Toll-like receptor 3 on synovial fibroblasts.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Congshan Jiang Research Topics

Disease

14	Arthritis (Polyarthritis) 01/2021 - 09/2009
13	Rheumatoid Arthritis 01/2021 - 01/2010
5	Inflammation (Inflammations) 01/2021 - 04/2016
5	Pneumonia (Pneumonitis) 04/2016 - 09/2009
4	Osteoarthritis 11/2020 - 06/2011
3	Experimental Arthritis 01/2021 - 01/2010
2	Synovitis 01/2021 - 01/2020
2	Synovial Sarcoma (Synovioma) 01/2018 - 11/2016
2	Cognitive Dysfunction 01/2018 - 10/2017
2	Asthma (Bronchial Asthma) 04/2016 - 02/2011
1	Neoplasms (Cancer) 01/2022
1	Brain Injuries (Brain Injury) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Binge Drinking 10/2020
1	Schizophrenia (Dementia Praecox) 10/2016
1	Respiratory Sounds (Crackle) 04/2016
1	Systemic Scleroderma (Systemic Sclerosis) 01/2015
1	Airway Remodeling 12/2014

Drug/Important Bio-Agent (IBA)

12	pristane (pristan)IBA 01/2021 - 09/2009
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
5	CytokinesIBA 11/2020 - 01/2015
5	AntigensIBA 04/2016 - 09/2009
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2014 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2016
3	Toll-Like Receptor 3IBA 01/2014 - 01/2010
2	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2020
2	HMGB1 Protein (HMG1)IBA 01/2019 - 11/2016
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2021
1	rat MIRN147 microRNAIBA 01/2021
1	rat MIRN155 microRNAIBA 01/2021
1	AntagomirsIBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Nicotine FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Interleukin-17 ReceptorsIBA 01/2021
1	InterleukinsIBA 11/2020
1	Matrix Metalloproteinases (MMPs)IBA 11/2020
1	Protons (Proton)IBA 10/2020
1	Ethanol (Ethyl Alcohol)IBA 10/2020
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	EnzymesIBA 01/2020
1	Large Neutral Amino Acid-Transporter 1IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	General AnestheticsIBA 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	Propofol (Diprivan)FDA LinkGeneric 10/2017
1	Interleukin-22 (IL-22)IBA 01/2017
1	oxymatrineIBA 11/2016
1	Therapeutic UsesIBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	GelatinIBA 01/2015
1	Peptidoglycan (Murein)IBA 04/2012
1	Toll-Like Receptor 2IBA 04/2012
1	Poly I-CIBA 06/2011
1	Pattern Recognition ReceptorsIBA 02/2011
1	Interleukin-4 (Interleukin 4)IBA 02/2011
1	Immunoglobulin E (IgE)IBA 02/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Intra-Articular Injections 11/2020
1	Subcutaneous Injections 06/2011